The Association between Major Depression and Levels of Soluble Intercellular Adhesion Molecule 1, Interleukin-6, and C-Reactive Protein in Patients with Recent Acute Coronary Syndromes

American Journal of Psychiatry

Volumn 161, Issue 2, 2004, Pages 271-277

  Lespérance, François ^a   Frasure Smith, Nancy ^b   Théroux, Pierre ^b   Irwin, Michael ^b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; STATINE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; FEMALE; GENDER; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; SMOKING; ACUTE DISEASE; BLOOD; BODY MASS; COMORBIDITY; METABOLISM; MIDDLE AGED; OBESITY; PREVALENCE;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; C-REACTIVE PROTEIN; COMORBIDITY; CORONARY DISEASE; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MALE; MIDDLE AGED; OBESITY; PREVALENCE;

EID: 1642446042     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.161.2.271     Document Type: Article

References (35)

1. Rozanski A, Blumenthal JA, Kaplan J: Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999; 99:2192-2217
2. Wulsin LR, Singal BM: Do depressive symptoms increase the risk for the onset of coronary disease? a systematic quantitative review. Psychosom Med 2003; 65:201-210
3. Ziegelstein RC, Fauerbach JA, Stevens SS, Romanielli J, Richter DP: Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 2000; 160:1818-1823
4. Musselman DL, Evans DL, Nemeroff CB: The relationship of depression to cardiovascular disease: epidemiology, biology and treatment. Arch Gen Psychiatry 1998; 55:580-592
5. Carney RM, Blumenthal JA, Stein PK, Watkins L, Catellier D, Berkman LF, Czajkowski SM, O'Connor C, Stone PH, Freedland KE: Depression, heart rate variability, and acute myocardial infarction. Circulation 2001; 104:2024-2028
6. Musselman DL, Marzec UM, Manatunga A, Penna S, Reemsnyder A, Knight BT, Baron A, Hanson SR, Nemeroff CB: Platelet reactivity in depressed patients treated with paroxetine. Arch Gen Psychiatry 2000; 57:875-882
7. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002; 105:1135-1143.
8. Appels A: Depression and coronary heart disease: observations and questions. J Psychosom Res 1997; 43:443-452
9. Liuzzo G, Biasucci LM: Markers of inflammation, in Acute Coronary Syndromes: A Companion to Braunwald's Heart Disease. Edited by Théroux P. Philadelphia, WB Saunders, 2003, pp 209-225
10. Ridker PM, Glynn RJ, Hennekens CH: C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998; 97: 2007-2011
11. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101:1767-1772
12. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J: Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998; 351:88-92
13. Lindmark E, Diderholm E, Wallentin L, Siegbahn A: Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA 2001; 286:2107-2113
14. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A: The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994; 331:417-424
15. Haim M, Tanne D, Boyko V, Reshef T, Goldbourt U, Leor J, Mekori YA, Behar S: Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease: data from the Bezafibrate Infarction Prevention (BIP) Study. J Am Coll Cardiol 2002; 39: 1133-1138
16. Connor TJ, Leonard BE: Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci 1998; 62:583-606
17. Anisman H, Merali Z: Cytokines, stress, and depressive illness. Brain Behav Immun 2002; 16:513-524
18. Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, McCorkle R, Seligman DA, Schmidt K: The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001; 15:199-226
19. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA: Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002; 90:1279-1283
20. Kop WJ, Gottdiener JS, Tangen CM, Fried LP, McBurnie MA, Walston J, Newman A, Hirsch C, Tracy RP: Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 2002; 89:419-424
21. Rajagopalan S, Brook R, Rubenfire M, Pitt E, Young E, Pitt B: Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol 2001; 88:196-198
22. Appels A, Bär FW, Bär J, Bruggeman C, De Baets M: Inflammation, depressive symptomatology, and coronary artery disease. Psychosom Med 2000; 62:601-605
23. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). New York, New York State Psychiatric Institute, Biometrics Research, 1996
24. Protocol for the bypass angioplasty revascularization investigation. Circulation 1991; 84(suppl V)(6):V1-V27
25. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497
26. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third Health and Nutrition Examination Survey. JAMA 2002; 287:356-359
27. SPSS Base 10.0 User's Guide. Chicago, SPSS, 1999
28. Jialal I, Stein D, Balis D, Grundy SM, Adams-Huet B, Devaraj S: Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation 2002; 103:1933-1935
29. Irwin M, Brown M, Patterson T, Hauger R, Mascovich A, Grant I: Neuropeptide Y and natural killer cell activity: findings in depression and Alzheimer caregiver stress. FASEB J 1991; 5:3100-3107
30. Redwine L, Snow S, Mills P, Irwin M: Acute psychological stress: effects on chemotaxis and cellular adhesion molecule expression. Psychosom Med 2003; 65:598-603
31. Mills PJ, Goebel M, Rehman J, Irwin M, Maisel AS: Leukocyte adhesion molecule expression and T cell naïve memory status following isoproterenol infusion. J Neuroimmunol 2000; 102: 137-144
32. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M: "Vascular depression" hypothesis. Arch Gen Psychiatry 1997; 54:915-922
33. Krishnan KRR, McDonald WM: Arteriosclerotic depression. Med Hypotheses 1995; 44:111-115
34. Thomas AJ, Ferrier IN, Kalaria RN, Woodward SA, Ballard C, Oakley A, Perry RH, O'Brien JT: Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. Am J Psychiatry 2000; 157:1682-1684
35. Maes M: Major depression and activation of the inflammatory response system. Adv Exp Med Biol 1999; 461:25-46